Skip to content

HealthEquity

US · HQY #1726 by market cap Listed 1970
91.90 +0.85 +0.93%
Live - 5344 symbols - heartbeat 13s ago · 2026-10-08 04:02
Pre-market 90.78 -1.22%
After-hours 91.90 0.00%
Market cap
7.60B
P/B
3.82
EPS
2.46
Reader sentiment Are you bullish or bearish on HQY?

Anonymous reader poll. Unscientific, not investment advice.

✦ Quant Ownership Signal how this is computed

Accumulating
  • The number of reporting institutions decreased by 5 in the most recent period (2026/Q3).
  • Total institutional ownership rose 0.5 percentage points.

Institutional ownership

Held by institutions
110.40% +0.51pp
Institutions
591 -5
As of
2026/Q3 vs. prior period

Ownership vs. money flow

Diverging

Institutions added shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Holder types

Mutual Fund92.44%
Hedge Fund8.79%
Public Company3.32%
Private Company2.46%
Individual/Insider1.99%
Government Pension Fund1.70%
Sovereign Wealth Fund0.69%
Family Office/Trust0.49%
Insurance Company0.44%

Top holders as of 2026-06-30

BlackRock 13.63% · 11.28M sh
Wasatch Advisors LP 9.62% · 7.96M sh
Vanguard Capital Management, LLC 5.13% · 4.24M sh
Vanguard Portfolio Management, LLC 4.91% · 4.06M sh
State Street Global Advisors 3.92% · 3.24M sh
Eaton Vance Management 2.94% · 2.43M sh
Geode Capital Management, LLC 2.87% · 2.37M sh
AQR Capital Management 2.41% · 1.99M sh
Dimensional Fund Advisors 2.26% · 1.87M sh
William Blair Investment Management, LLC 2.21% · 1.83M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 20 buys · 27 sells

NameRoleStake
Stephen Neeleman Founder & Vice Chairman 1.03%
Jon Kessler Chief Executive Officer 0.40%
Robert Selander Independent Non-Executive Chairperson 0.11%
Elimelech Rosner Former Chief Technology Officer 0.10%
Adrian Dillon Independent Director 0.07%
Delano Ladd General Counsel 0.07%
Evelyn Dilsaver Independent Director 0.06%
James Lucania Chief Financial Officer 0.04%
Stuart Parker Independent Director 0.03%
Scott Cutler Chief Executive Officer 0.03%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-09-23 Noemie Heuland Director Initial Statement of Beneficial 0 --
2026-09-16 Stephen Neeleman Founder & Vice Chairman Other Disposition -1,500 --
2026-08-24 Adrian Dillon Independent Director Derivative Exercise and Sale -7,632 $32.50–105.26
2026-07-09 Michael Fiore Executive Vice President Open Market Disposition -2,354 $95.00
2026-07-08 Michael Gathright -- Sale to Issuer -2,270 $93.07
2026-07-07 James Lucania Chief Financial Officer Sale to Issuer -2,839 $95.08
2026-07-07 Stephen Neeleman Founder & Vice Chairman Sale to Issuer -1,103 $95.08
2026-07-07 Scott Cutler Chief Executive Officer Sale to Issuer -1,238 $95.08
2026-07-07 Delano Ladd General Counsel Sale to Issuer -1,087 $95.08
2026-07-07 Michael Fiore Executive Vice President Sale to Issuer -2,045 $95.08
2026-07-01 Michael Fiore Executive Vice President Automatic Disposition -2,470 $95.00
2026-06-24 Adrian Dillon Independent Director Other Acquisition +2,877 --
2026-06-24 Robert Selander Independent Non-Executive Chairperson Other Acquisition +2,877 --
2026-06-24 Evelyn Dilsaver Independent Director Other Acquisition +2,877 --
2026-06-24 Stuart Parker Independent Director Other Acquisition +2,877 --
2026-06-24 Gayle Wellborn Independent Director Other Acquisition +2,877 --
2026-06-24 Debra McCowan Independent Director Other Acquisition +2,877 --
2026-06-24 Rajesh Natarajan Independent Director Other Acquisition +2,877 --
2026-06-24 William Gassen Director Other Acquisition +2,877 --
2026-05-28 Michael Fiore Executive Vice President Automatic Disposition -3,142 $95.00

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-10-08 04:02:46 · For reference only, not investment advice and not tailored to your situation.